High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
- 568 Downloads
To identify which breast lesion descriptors in the ACR BI-RADS® MRI lexicon are most strongly associated with the diagnosis of breast cancer when performing breast MR imaging at 3 T.
150 patients underwent breast MR imaging at 3 T. Lesion size, morphology and enhancement kinetics were assessed according to the BI-RADS® classification. Sensitivity, specificity and diagnostic accuracy were assessed. The effects of the BI-RADS® descriptors on sensitivity and specificity were evaluated. Data were analysed using logistic regression. Histopathological diagnoses were used as the standard of reference.
The sensitivity, specificity and diagnostic accuracy of breast MRI at 3 T was 99%, 81% and 93%, respectively. In univariate analysis, the final diagnosis of malignancy was positively associated with irregular shape (p < 0.001), irregular margin (p < 0.001), heterogeneous enhancement (p < 0.001), Type 3 enhancement kinetics (p = 0.02), increasing patient age (p = 0.02) and larger lesion size (p < 0.001). In multivariate analysis, significant associations with malignancy remained for mass shape (p = 0.06), mass margin (p < 0.001), internal enhancement pattern (p = 0.03) and Type 3 enhancement kinetics (p = 0.06).
The ACR BI-RADS® breast lesion descriptors that are mostly strongly associated with breast cancer in breast MR imaging at 3 T are lesion shape, lesion margin, internal enhancement pattern and Type 3 enhancement kinetics.
• 3 Tesla breast MRI allows an accurate diagnosis of breast cancer
• The BI-RADS® descriptors help provide a confident diagnosis
• The shape, margin, enhancement pattern and kinetics are the most important features
• An irregular shape and margin, heterogeneous enhancement and type-3 kinetics indicate malignancy
KeywordsBI-RADS® 3 Tesla MRI Breast cancer Lesion descriptors
- 16.Radiology RVACo (2003) American College of Radiology (ACR). Breast Imaging and Reporting Data System (BI-RADS). (4th ed.)Google Scholar
- 32.Pathologists RCo (2001) NHS Cancer Screening Programes: Guidelinesfor non-operative diagnostic procedures and reporting in breast cancer screening(ed)^(eds). NSHBSP publication, SheffieldGoogle Scholar
- 33.Pathology EWGoBS (2006) Quality assurance guidelines for pathologyEuropean guidelines for quality assurance in cancer screening and diagnosis, 4th edn. European Union, pp 219–312Google Scholar
- 41.Pinker K, Stadlbauer A, Bogner W, Gruber S, Helbich TH (2010) Molecular imaging of cancer: MR spectroscopy and beyond. Eur J RadiolGoogle Scholar
- 44.Gruber S., Debski B, Pinker K, et al. Three dimensional proton magnetic resonance spectroscopic imaging (3D-MRSI) for differentiation of benign and malignant breast lesions at 3 Tesla. RadiologyGoogle Scholar